DXC vs EPAM Stock Comparison
Compare DXC and EPAM across AIQ Score, fundamentals, valuation, momentum, risk, analyst expectations and current market evidence.
What is the main difference between DXC and EPAM?
EPAM leads the current stock comparison as EPAM Systems, Inc., with the clearest separation coming from quality and the broader AIQ evidence mix.
AlgovestIQ AIQ Comparison
DXC Technology Company vs EPAM Systems, Inc.
EPAM leads
EPAM leads by 14 AIQ points, primarily on Quality and Risk Resilience. Wall Street currently favors DXC on target upside.
Competitive: 3 of 6 evidence groups support EPAM.
DXC Technology Company
EPAM Systems, Inc.
The Algovestiq AIQ Score currently favors EPAM over DXC, 64 versus 50 as of Sep 11, 2026. EPAM's advantage is driven primarily by stronger quality and risk resilience. EPAM also shows the stronger technical structure relative to its 50-day moving average, though analyst target upside currently favors DXC. 3 of 6 covered evidence groups favor EPAM today, and the comparison is rated Competitive on stability: only 3 of 6 covered evidence groups agree. EPAM lead: Stable — the AIQ differential has held near 14 points over 30 sessions.
Compare DXC Technology Company and EPAM Systems, Inc. across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.
Performance over time
Price-return comparison using available daily close history.
Total return comparison
Growth of $10,000
Based on available close-price history. Distribution reinvestment is not added unless already reflected in the source series.
Compare DXC and EPAM against another ticker
Open a multi-ticker workspace without changing this focused pair page.
AIQ Factor Divergence
Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.
- Quality20 vs 53EPAM +33
- Risk Resilience46 vs 60EPAM +14
- Momentum59 vs 66EPAM +7
- Value75 vs 74Even
3 of 6 evidence groups favor EPAM. EPAM’s edge is concentrated in quality and risk resilience.
What changed since the last close
Latest scored session 2026-09-10, compared against the prior scored session 2026-09-09.
Largest factor move: Momentum +3
No new signals fired.
No factor moved materially.
No new signals fired.
EPAM's lead narrowed by 1 AIQ points in the latest snapshot.
Deeper signal detail for each name lives on its own signals page — DXC and EPAM both carry a full feed there.
The central trade-off
EPAM (EPAM Systems, Inc.): the stronger current systematic profile, led by quality and risk resilience.
DXC (DXC Technology Company): the counter-case, on analyst expectations — but at materially higher volatility, 44% against 36.8%.
The AIQ Score and Wall Street therefore point in different directions on this pair.
Which one fits your objective
The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.
Balanced
EPAMEPAM on the overall AIQ Score, which weights Quality and Value most heavily.
Growth
DXCDXC on combined revenue and EPS growth.
Value
EvenThe two are level on Value.
Momentum
EPAMEPAM on the Momentum factor, by 7 points.
Lower downside
EPAMEPAM on Risk Resilience, by 14 points.
Analyst upside
DXCDXC on implied upside to the consensus price target.
AIQ vs Wall Street
The model and the Street disagree here: AIQ favors EPAM, analyst targets favor DXC. That disagreement is the most useful thing on this page.
| Measure | DXC | EPAM | Note |
|---|---|---|---|
| Implied upside to target | +10.8% | +4.8% | DXC has more room |
| Target dispersion | +43.6% | +93.1% | Lower is tighter analyst agreement |
| Consensus | Hold | Buy | Context, not a primary driver |
| Analysts covering | 3 | 12 | Higher coverage generally improves confidence |
The two are measuring different things. The AIQ Score reads current fundamentals, valuation, trend and risk; analyst targets price forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something already priced in — it is worth resolving before acting on either.
Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.
AIQ Agreement Matrix
3 of 6 covered evidence groups favor EPAM. A wide gap backed by one group is a weaker case than a narrow gap backed by five.
| Evidence group | Favors | Reading |
|---|---|---|
| AIQ Score | EPAM | 50 vs 64 |
| Fundamentals | EPAMon balance | revenue growth -4.2% vs 1.1%; EPS growth 193.8% vs 28.8%; TTM ROE 4.1% vs 11.2%; gross margin 13.7% vs 28.3%; operating margin 3.4% vs 10.3% — EPAM takes 4 of 5 decided legs, not all of them |
| Valuation | Even | Value 75 vs 74 |
| Technicals | Even | Price vs 50-day 8.4% vs 17.3%; vs 200-day -7.1% vs -16.6% |
| Risk Resilience | EPAM | Risk Resilience 46 vs 60 |
| Analyst expectations | DXC | Target upside 10.8% vs 4.8% |
✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of DXC and EPAM and are excluded from the count.
AIQ Decision Stability
The two are close enough that your objective, not the score, should decide.
- The AIQ gap is wide at 14 points. (supports the conclusion holding)
- Only 3 of 6 covered evidence groups agree. (argues the conclusion is provisional)
- The lead has been steady session to session. (supports the conclusion holding)
- Analyst targets on the leader are widely dispersed. (argues the conclusion is provisional)
Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on EPAM.
How the comparison changed
119 daily snapshots · May 4 – Sep 10EPAM lead: Stable — the AIQ differential has held near 14 points over 30 sessions.
- Today
- EPAM +14
- 50 vs 64
- 7 sessions ago
- EPAM +12
- 54 vs 66
- 30 sessions ago
- EPAM +14
- 47 vs 61
- 90 sessions ago
- EPAM +5
- 52 vs 57
The lead has not changed hands in this window.
AIQ Signal Divergence
Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.
0 bullish / 2 bearish / 2 neutral
- Death Cross Active — bearish, trend, long horizon (13.11%)
- Bollinger Band Squeeze — neutral, volatility, short horizon
- ATR Expansion - Breakout Mode — neutral, volatility, short horizon (4.36%)
0 bullish / 2 bearish / 1 neutral
- Death Cross Active — bearish, trend, long horizon (36.57%)
- ATR Expansion - Breakout Mode — neutral, volatility, short horizon (4.19%)
- MACD Bearish Crossover — bearish, momentum, short horizon
Price vs model alignment
Whether the latest session's price move confirms what the model did over the same session, or contradicts it.
Price and the AIQ Score both moved up over the latest session (price +3.17%, AIQ +1 points).
Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price +2.96%, AIQ 0 points).
What would flip this result
A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.
- 1DXC closes the Quality gap — currently 33 points behind, the largest single contributor to EPAM's edge.
- 2DXC's Death Cross Active resolves — a bearish trend rule currently active against it.
- 3EPAM starts generating bearish momentum or trend signals.
- 4A regime shift changes factor weighting — Quality and Value carry the heaviest weights in the composite, so a rotation toward either would move the result most.
The full evidence
Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.
Fundamentals
EPAM leads on balance| Metric | DXC | EPAM |
|---|---|---|
| Revenue growth (YoY) | -4.2% | 1.1% |
| EPS growth (YoY) | 193.8% | 28.8% |
| Gross margin | 13.7% | 28.3% |
| Operating margin | 3.4% | 10.3% |
| Return on equity (TTM) | 4.1% | 11.2% |
| Debt to equity | 1.37 | 0.04 |
Performance
DXC leads 4 of 6 windows| Metric | DXC | EPAM |
|---|---|---|
| 1 week (5 sessions) | -5.1% | -2.3% |
| 1 month (20 sessions) | 3.4% | 14.2% |
| 3 months (63 sessions) | 25.2% | 23.1% |
| 6 months (126 sessions) | -10.2% | -19.3% |
| Year to date | -24.6% | -44.1% |
| 1 year (252 sessions) | -24.6% | -30.4% |
Technicals
Split| Metric | DXC | EPAM |
|---|---|---|
| RSI (14) | 55.5 | 64.7 |
| ADX (14) | 30 | 23.8 |
| Price vs 50-day | 8.4% | 17.3% |
| Price vs 200-day | -7.1% | -16.6% |
| Volatility (1M, annualized) | 44% | 36.8% |
Risk
EPAM is the more resilient| Metric | DXC | EPAM |
|---|---|---|
| Beta | 0.61 | 0.58 |
| Sharpe ratio | -0.26 | -0.53 |
| Sortino ratio | -0.33 | -0.6 |
| Max drawdown | -46.7% | -65.7% |
| Current drawdown | -28.4% | -48.3% |
| Annualized volatility | 56% | 51.3% |
| Value at risk (95%) | -5.5% | -5% |
Straight answers
Each answer is regenerated from the current snapshot, not written once and left to age.
Which is better, DXC or EPAM?
On the Algovestiq AIQ Score, EPAM is the stronger of the two as of Sep 11, 2026, scoring 64 against DXC's 50. The edge comes from quality and risk resilience. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.
Is DXC or EPAM the better buy right now?
EPAM carries the stronger systematic profile as of Sep 11, 2026, and the comparison is rated Competitive — 3 of 6 covered evidence groups agree. A Competitive rating means the two are close enough that your objective, not the score, should decide.
Why does the AIQ Score favor EPAM over DXC?
The composite weights Quality, Value, Momentum and Risk Resilience. EPAM leads Quality by 33 points; EPAM leads Risk Resilience by 14 points; EPAM leads Momentum by 7 points. Where the two split, the factor with the larger weight carries the result.
Which has more analyst upside, DXC or EPAM?
Analyst price targets imply +10.8% upside for DXC and +4.8% for EPAM, so the Street currently favors DXC. That points the opposite way to the AIQ Score, which favors EPAM. The two are measuring different things: the model reads current fundamentals, valuation, trend and risk; the Street is pricing forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something the analysts have already priced — it is the single most useful row on this page to investigate. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.
Which is better value, DXC or EPAM?
Neither name separates on the peer-relative Value factor. The two are level on Value. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.
Which has stronger growth, DXC or EPAM?
DXC on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.
Which has stronger momentum, DXC or EPAM?
EPAM on the Momentum factor, by 7 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.
Which is riskier, DXC or EPAM?
EPAM is the more resilient of the two, so the other name carries the higher downside risk. EPAM on Risk Resilience, by 14 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.
Is DXC more profitable than EPAM?
EPAM leads on the comparable margin measures — gross margin 13.7% vs 28.3%; operating margin 3.4% vs 10.3%; ttm roe 4.1% vs 11.2%.
Is EPAM's lead over DXC getting stronger or weaker?
EPAM lead: Stable — the AIQ differential has held near 14 points over 30 sessions. This is measured from 119 daily comparison snapshots between 2026-05-04 and 2026-09-10. The lead has not changed hands in that window.
What would change the DXC vs EPAM verdict?
The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: DXC closes the Quality gap — currently 33 points behind, the largest single contributor to EPAM's edge; DXC's Death Cross Active resolves — a bearish trend rule currently active against it; EPAM starts generating bearish momentum or trend signals; a regime shift changes factor weighting — Quality and Value carry the heaviest weights in the composite, so a rotation toward either would move the result most.
What do the current signals say about DXC and EPAM?
DXC: 0 bullish / 2 bearish / 2 neutral. EPAM: 0 bullish / 2 bearish / 1 neutral. The most decision-relevant rule on DXC is Death Cross Active (bearish, long horizon). On EPAM it is Death Cross Active (bearish, long horizon).
Compare DXC and EPAM with others
Continue your research
This page answers which of the two. These answer the questions on either side of it.
How this comparison is scored
The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.
The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.
How to use side-by-side comparison →This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.